The effect of intraperitoneal interleukin-2 on surgically induced endometriosis in rats

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 136, Issue 2, 2008, Pages 243-248

  Quereda, Francisco ^a   Bermejo, Rosa ^a   Velasco, Irene ^a   Campos, Adolfo ^a,b   Acién, Pedro ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Blood Bank Center of San Juan   (Spain)

Author keywords

Experimental endometriosis; Immune stimulation; Interleukin 2; Rat

Indexed keywords

INTERLEUKIN 2; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; LAPAROTOMY; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; WISTAR RAT;

EID: 38649142131     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.11.021     Document Type: Article

References (30)

1. Dmowski W.P., Steele R.W., and Baker G.F. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 141 4 (1981) 377-383
2. Weed J.C., and Arquembourg P.C. Endometriosis: can it produce an autoimmune response resulting in infertility?. Clin Obstet Gynecol 23 3 (1980) 885-893
3. Paul Dmowski W., and Braun D.P. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18 2 (2004) 245-263
4. Ho H.N., Wu M.Y., and Yang Y.S. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 38 6 (1997) 400-412
5. Raiter-Tenenbaum A., Baranao R.I., Etchepareborda J.J., Meresman G.F., and Rumi L.S. Functional and phenotypic alterations in peritoneal macrophages from patients with early and advanced endometriosis. Arch Gynecol Obstet 261 3 (1998) 147-157
6. Jones R.K., Bulmer J.N., and Searle R.F. Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Hum Reprod Update 4 5 (1998) 702-709
7. Oosterlynck D.J., Meuleman C., Waer M., Vandeputte M., and Koninckx P.R. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 58 2 (1992) 290-295
8. Hill J.A. Immunology and endometriosis. Fact, artifact, or epiphenomenon?. Obstet Gynecol Clin North Am 24 2 (1997) 291-306
9. Melioli G., Semino C., Semino A., Venturini P.L., and Ragni N. Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis. Am J Reprod Immunol 30 4 (1993) 218-227
10. Acien P., Quereda F.J., Gomez-Torres M.J., Bermejo R., and Gutierrez M. GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis. Gynecol Obstet Invest 55 2 (2003) 96-104
11. Acien P., Quereda F., Campos A., Gomez-Torres M.J., Velasco I., and Gutierrez M. Use of intraperitoneal interferon alpha-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial. Fertil Steril 78 4 (2002) 705-711
12. Quereda F., Barroso J., and Acien P. Individual and combined effects of triptoreline and gestrinone on experimental endometriosis in rats. Eur J Obstet Gynecol Reprod Biol 67 1 (1996) 35-40
13. Ingelmo J.M., Quereda F., and Acien P. Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in a murine model. Fertil Steril 71 5 (1999) 907-911
14. Jones R.C. The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. Acta Endocrinol (Copenh) 106 2 (1984) 282-288
15. Vernon M.W., and Wilson E.A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44 5 (1985) 684-694
16. Uchiide I., Ihara T., and Sugamata M. Pathological evaluation of the rat endometriosis model. Fertil Steril 78 4 (2002) 782-786
17. Vernon M.W. Experimental endometriosis in laboratory animals as a research model. Prog Clin Biol Res 323 (1990) 49-60
18. Sharpe K.L., Bertero M.C., Muse K.N., and Vernon M.W. Spontaneous and steroid-induced recurrence of endometriosis after suppression by a gonadotropin-releasing hormone antagonist in the rat. Am J Obstet Gynecol 164 1, Part 1 (1991) 187-194
19. Kaushic C., Frauendorf E., Rossoll R.M., Richardson J.M., and Wira C.R. Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract. Am J Reprod Immunol 39 3 (1998) 209-216
20. Keenan J.A., Williams-Boyce P.K., Massey P.J., Chen T.T., Caudle M.R., and Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 72 1 (1999) 135-141
21. Somigliana E., Vigano P., Rossi G., Carinelli S., Vignali M., and Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod 14 12 (1999) 2944-2950
22. Uygur D., Aytan H., Zergeroglu S., and Batioglu S. Leflunomide - an immunomodulatory - induces regression of endometrial explants in a rat model of endometriosis. J Soc Gynecol Investig 13 5 (2006) 378-383
23. Hsieh Y.Y., Chang C.C., Tsai F.J., Hsu C.M., Lin C.C., and Tsai C.H. Interleukin-2 receptor beta (IL-2R beta)-627*C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis. Fertil Steril 84 2 (2005) 510-512
24. Keenan J.A., Chen T.T., Chadwell N.L., Torry D.S., and Caudle M.R. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 34 6 (1995) 381-385
25. Calleja C., Eeckhoutte C., Dacasto M., et al. Comparative effects of cytokines on constitutive and inducible expression of the gene encoding for the cytochrome P450 3A6 isoenzyme in cultured rabbit hepatocytes: consequences on progesterone 6beta-hydroxylation. Biochem Pharmacol 56 10 (1998) 1279-1285
26. Cordel S., Dupas B., Douillard J.Y., and Meflah K. Interleukin-2/sodium butyrate treatment cures rats bearing liver tumors after acquired 5-fluorouracil resistance. Int J Cancer 78 6 (1998) 735-739
27. Saffran D.C., Horton H.M., Yankauckas M.A., et al. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity. Cancer Gene Ther 5 5 (1998) 321-330
28. Fiszer-Maliszewska L., Den Otter W., and Mordarski M. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength. Cancer Immunol Immunother 47 6 (1999) 307-314
29. Anderson T.D., Hayes T.J., Gately M.K., Bontempo J.M., Stern L.L., and Truitt G.A. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes. Separation of efficacy and toxicity by selective lymphocyte subset depletion. Lab Invest 59 5 (1988) 598-612
30. Wolfgang G.H., McCabe R.D., and Johnson D.E. Toxicity of subcutaneously administered recombinant human interleukin-2 in rats. Toxicol Sci 42 1 (1998) 57-63